Uscid est ad quis et lam sitatium commoloribus solupta illaborum doloria alisci dioribus si quis porereh enianimus mollam, quo maxim quis ma senimus, alit,Deles etusapici am, inusdae commodi cupiderro doluptas acipsap elignatio omnihilla inihiliciu Denihit doluptamus ut ped ut eatinie ndandem. Quae. Olut exerios dipsum nis
Experts from around the globe describe the intersection between patient and healthcare worker safety, focusing on techniques to improve both occupational and public health.
Webinar Objectives:
- Describe the current global impact of bloodborne disease
- Describe occupational exposure incidents for needlesticks and sharps injuries
- Define safety as a function of focus for both patient and health worker, to reduce overall bloodborne disease
- Provide guidance on the importance of prevention programs including use of safer medical devices, immunization/vaccination programs, and safe clinical practices
- Illustrate an effective pathway for reporting exposure incidents and injuries
- Define processes for post-exposure medical treatment and prophylaxis
- Share global experiences from key stakeholders responsible for sharps safety and public health programs around the world
Save Your Seat
BD Nano™ 2nd Gen Pen Needles
Easier injections from start to finish4§
Not all 4mm pen needles are the same.
click here to learn more about BD Nano™ 2nd Gen Pen Needles
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Access our Educational Tools
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Let's have a conversation
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Did you know?
Nearly 50% of patients reuse their needles1*
Reusing the same needle has been associated with injection pain and increased risk of developing lipohypertrophy (lumps and bumps under the skin) at injection sites.1+
Lipohypertrophy can contribute to erratic insulin absorption, increase glycemic variability, and unexplained hypoglycemic episodes.2^
Pellentesque habitant morbi
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Download Now
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Store Tab
360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.
360° rotation knob is effectively sized
360° rotation knob is effectively sized
360° rotation knob is effectively sized
Store Tab
360° rotation knob is effectively sized, contoured and located to enable easy instrument rotation.
360° rotation knob is effectively sized
360° rotation knob is effectively sized
360° rotation knob is effectively sized
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
Hospitals and healthcare facilities
BD is a market leader in hospital products that can reduce the incidence of sharps injuries and exposure to bloodborne pathogens. Patient safety has been a focus of BD innovation for years, not only in the United States but also around the world. Working closely with organizations like the International Safety Center (EPINet) is an important part of our efforts to keep patients and workers safe.
Safety syringes and needles >>
Hazardous drug safety >>
Infection prevention >>
When refilling insulin, ask your patients if they need a refill of needles.
Ibus exped et ape
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.
Pellentesque habitant morbi
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
- Tristique senectus et netus et malesuada
Fill out the form below to receive your Patient Counseling Toolbox with free samples
FOOTNOTES
*
13,289 patients with diabetes who inject insulin participated in an injection technique questionnaire. 38.8% of the 2,711 patients using insulin syringes reported needle reuse. 55.8% of the 11,961 patients using pen needles reported needle reuse.
†
A causal relationship has not been established. 13,289 insulin-injecting patients participated in a survey. Logistic regression analysis was used to find the association between pen needle reuse and LH (P=.02). Pain was associated with needle reuse and is a function of the number of times the needle is reused (P<.001).
‡
430 patients with diabetes who had been injecting insulin for at least 1 year were observed on their injection technique (i.e., site rotation, area of injection, frequency of needle/syringe reuse) as well as the presence of lipohypertrophy (LH). 39% of patients with LH reported having episodes of unexplained hypoglycemia vs. 6% without LH [p<0.01]. "Frequent unexplained hypoglycemia" was defined as having a hypoglycemic episode (blood glucose reading of ≤ 60 mg/dL) one or more times a week in the absence of a definable precipitating event, such as a change in medication, diet or activity.
§
226 patients with diabetes on insulin treatment were studied with a 150 mm visual analog scale (mean scores of >0 mm; clinically significant difference of ≥ 5 mm ). BD Nano 2nd Gen demonstrated superiority vs. all comparator groups combined for feeling more comfortable throughout injection experience and for overall ease of use. [Comfort (P <0 .05 ) (Mean +18 .0 mm, 95 % CI, +11 .6 to +24 .3mm) ]; [Easier (P <0 .05 ) (Mean 19 .9 mm, 95 % CI, +13 .8 to +25 .9mm)].
REFERENCES
-
Frid AH, et al. Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices. Mayo Clin Proc. 2016;91(9):1212-1223.
-
American Diabetes Association. Standards of Medical Care in Diabetes - 2023. Diabetes Care. 2023;46(Suppl 1):S1-298.
-
Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445-453.
-
Whooley S, Briskin T, Gibney MA, Blank LR, Berube J, Pflug BK. Evaluating the User Performance and Experience with a Re-Engineered 4 mm × 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
embecta, formerly part of BD, is now one of the largest pure-play diabetes management companies in the world. This singular focus allows us to leverage our nearly 100-year legacy in insulin delivery, while empowering people with diabetes to live their best life through innovative solutions, partnerships, and the passion of over 2,000 employees around the globe.
- Follow Us
-
-
